USDM Life Sciences announced that EUDAMED has landed, now at MVP status, with basic UDI-DI mandatory and unchangeable once set, new devices must register before market placement, and existing devices have a strict 6-month window.
Public source
Publisher name
Public post
EUDAMED has landed — 5+ years behind schedule, now at MVP status. Basic UDI-DI is mandatory and unchangeable once set, new devices must register before market placement,…
Company
USDM Life Sciences
Evolving regulated operations to accelerate innovation.
- Industry
- IT Services and IT Consulting
- Location
- Santa Barbara, US
- Company size
- 51–200 employees
About USDM Life Sciences
At USDM Life Sciences, we empower life sciences organizations to drive innovation through intelligent operations. By integrating AI, automation, and digital quality systems, we help biotech, pharma, and medical device companies deliver transformative results. Trusted by global technology leaders and life sciences organizations alike, we ensure seamless alignment between compliance and cutting-edge innovation. With tailored solutions that evolve regulated tasks, we enable our customers to achieve measurable outcomes with agility and confidence.
See moreLatest activity
Latest activity from USDM Life Sciences
26 signals
Products & Services
USDM Life Sciences built ProcessX with ServiceNow to address Abbott's unreliable software inventory and validation process issues.
Presence & Recognition
USDM Life Sciences is attending RAPS Convergence 2026 in Charlotte on September 15 to host a Lunch & Learn session on managing global UDI compliance and device registration strategies.
Research & Knowledge
USDM Life Sciences published an analysis written as Boston Scientific's cyberattack unfolded that breaks down why business impact, not just data exposure, is the real measure of cyber resilience.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
material.one AG
material.one AG announced that since 28 May 2026, the first four EUDAMED modules are mandatory including Actor Registration, UDI / Device Registration, Notified Bodies & Certificates, and Market Surveillance.
Presence & Recognition
MedQAIR
MedQAIR participated in the next European SaMD Meetup to discuss the Status of the AI Act and Standards.
Presence & Recognition
Hardian Health
Hardian Health contributed to the stakeholder panel on medical device submission documentation.
Presence & Recognition
RQM+
RQM+ regulatory experts are hosting an audience-driven discussion on September 17 featuring Scarlet and questions on AI-enabled medical devices, the EU MDR landscape, the EU AI Act, AI management systems, and conformity assessment issues.
Presence & Recognition
Vellum Strategy Group